$CBRE
CBRE GROUP, INC. Stock $cbre

$cbre Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000113811823000015 Filed on April 27, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$7.720B	$7.411B	$7.333B
YoY Change	-0.66%	1.07%	23.47%
Cost Of Revenue	$6.179B	$6.006B	$5.752B
YoY Change	2.07%	4.42%	21.88%
Gross Profit	$1.540B	$1.405B	$1.581B
YoY Change	-10.3%	-11.14%	29.64%
Gross Profit Margin	19.95%	18.95%	21.56%
Selling, General & Admin	$1.089B	$1.209B	$1.066B
YoY Change	-8.41%	13.41%	28.7%
% of Gross Profit	70.69%	86.06%	67.44%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$154.4M	$161.5M	$149.0M
YoY Change	-4.91%	8.36%	22.06%
% of Gross Profit	10.02%	11.5%	9.43%
Operating Expenses	$1.243B	$1.370B	$1.215B
YoY Change	-7.99%	12.79%	27.83%
Operating Profit	$297.2M	$37.37M	$377.0M
YoY Change	-42.51%	-90.09%	40.09%
Interest Expense	-$50.48M	$113.3M	$30.05M
YoY Change	-150.16%	276.99%	-59.12%
% of Operating Profit	-16.99%	303.14%	7.97%
Other Income/Expense, Net	$5.612M	$2.475M	-$14.46M
YoY Change	-181.23%	-117.11%	-629.43%
Pretax Income	$261.6M	$153.1M	$392.5M
YoY Change	-57.17%	-60.99%	13.68%
Income Tax	$55.40M	$28.04M	-$3.738M
% Of Pretax Income	21.18%	18.31%	-0.95%
Net Earnings	$201.4M	$116.9M	$392.3M
YoY Change	-58.67%	-70.2%	47.37%
Net Earnings / Revenue	2.61%	1.58%	5.35%
Basic Earnings Per Share	$0.65	$0.38	$1.18
Diluted Earnings Per Share	$0.64	$0.37	$1.16
COMMON SHARES
Basic Shares Outstanding	310.8M shares	309.9M shares	331.9M shares
Diluted Shares Outstanding	314.3M shares	315.4M shares	337.1M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.261B	$1.231B	$1.657B
YoY Change	5.73%	-25.7%	-13.23%
Cash & Equivalents	$1.261B	$1.231B	$1.657B
Short-Term Investments
Other Short-Term Assets	$1.084B	$611.1M	$543.4M
YoY Change	62.06%	12.46%	70.5%
Inventory
Prepaid Expenses	$352.7M	$329.4M	$333.7M
Receivables	$5.922B	$5.469B	$5.073B
Other Receivables	$1.202B	$992.7M	$1.239B
Total Short-Term Assets	$9.470B	$9.046B	$9.334B
YoY Change	6.73%	-3.08%	18.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.932B	$833.3M	$792.7M
YoY Change	148.11%	5.11%	2.38%
Goodwill	$5.044B	$4.934B	$4.977B
YoY Change	5.19%	-0.87%	30.81%
Intangibles	$2.130B	$2.153B	$2.339B
YoY Change	-5.61%	-7.94%	70.64%
Long-Term Investments	$1.307B	$1.295B	$1.124B
YoY Change	8.74%	15.19%	64.72%
Other Assets	$1.644B	$1.135B	$869.7M
YoY Change	80.15%	30.46%	16.17%
Total Long-Term Assets	$12.26B	$11.98B	$11.81B
YoY Change	6.02%	1.47%	26.41%
TOTAL ASSETS
Total Short-Term Assets	$9.470B	$9.046B	$9.334B
Total Long-Term Assets	$12.26B	$11.98B	$11.81B
Total Assets	$21.73B	$21.03B	$21.14B
YoY Change	6.33%	-0.53%	22.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.886B	$3.008B	$2.882B
YoY Change	2.15%	4.39%	16.72%
Accrued Expenses	$2.622B	$2.576B	$2.706B
YoY Change	-5.87%	-4.83%	22.01%
Deferred Revenue	$263.7M	$262.2M	$295.6M
YoY Change	-6.49%	-11.3%	69.5%
Short-Term Debt	$1.586B	$1.992B	$1.413B
YoY Change	16.17%	40.96%	107.48%
Long-Term Debt Due	$471.8M	$433.4M	$37.08M
YoY Change	1410.39%	1069.04%	2544.51%
Total Short-Term Liabilities	$8.153B	$8.717B	$7.790B
YoY Change	6.94%	11.91%	34.94%
LONG-TERM LIABILITIES
Long-Term Debt	$2.124B	$1.086B	$1.526B
YoY Change	41.24%	-28.83%	-17.43%
Other Long-Term Liabilities	$2.282B	$1.045B	$950.2M
YoY Change	162.54%	9.95%	56.07%
Total Long-Term Liabilities	$4.405B	$2.131B	$2.476B
YoY Change	85.68%	-13.95%	0.78%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.153B	$8.717B	$7.790B
Total Long-Term Liabilities	$4.405B	$2.131B	$2.476B
Total Liabilities	$13.63B	$12.39B	$11.86B
YoY Change	18.11%	4.45%	23.64%
SHAREHOLDERS EQUITY
Retained Earnings	$9.011B	$8.810B	$8.759B
YoY Change	-0.81%	0.58%	28.88%
Common Stock	$15.62M	$3.108M	$412.5M
YoY Change	384.91%	-99.25%	-59.43%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.098B	$7.860B	$8.470B
YoY Change
Total Liabilities & Shareholders Equity	$21.73B	$21.03B	$21.14B
YoY Change	6.33%	-0.53%	22.58%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$201.4M	$116.9M	$392.3M
YoY Change	-58.67%	-70.2%	47.37%
Depreciation, Depletion And Amortization	$154.4M	$161.5M	$149.0M
YoY Change	-4.91%	8.36%	22.06%
Cash From Operating Activities	-$10.87M	-$744.8M	-$393.5M
YoY Change	-102.39%	89.26%	103.42%
INVESTING ACTIVITIES
Capital Expenditures	$74.73M	$60.28M	$42.06M
YoY Change	-236.7%	43.34%	42.1%
Acquisitions
YoY Change
Other Investing Activities	-$179.5M	-$4.074M	$4.487M
YoY Change	0.49%	-190.8%	-28143.75%
Cash From Investing Activities	-$254.3M	-$115.1M	-$95.62M
YoY Change	8.97%	20.34%	-50.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$367.9M
YoY Change			501.99%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	313.7M	$761.0M	-$209.0M
YoY Change	-156.89%	-464.12%	-152.0%
NET CHANGE
Cash From Operating Activities	-10.87M	-$744.8M	-$393.5M
Cash From Investing Activities	-254.3M	-$115.1M	-$95.62M
Cash From Financing Activities	313.7M	$761.0M	-$209.0M
Net Change In Cash	48.62M	-$85.06M	-$747.2M
YoY Change	-114.72%	-88.62%	1890.28%
FREE CASH FLOW
Cash From Operating Activities	-$10.87M	-$744.8M	-$393.5M
Capital Expenditures	$74.73M	$60.28M	$42.06M
Free Cash Flow	-$85.60M	-$805.0M	-$435.6M
YoY Change	-116.81%	84.83%	95.28%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	CBRE GROUP, INC.
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001138118
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2023Q1	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2022Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-32205
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	94-3391143
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	2100 McKinney Avenue
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1250
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75201
CY2023Q1	dei	City Area Code CityAreaCode	214
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	979-6100
CY2023Q1	dei	Security12b Title Security12bTitle	Class A Common Stock, $0.01 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	“CBRE”
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	310832322	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1231325000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1318290000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	88464000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	86559000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	92086000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	92354000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5468926000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5326807000	usd
CY2023Q1	cbre	Loan Receivable Mortgage Warehouse Lending Current LoanReceivableMortgageWarehouseLendingCurrent	792294000	usd
CY2022Q4	cbre	Loan Receivable Mortgage Warehouse Lending Current LoanReceivableMortgageWarehouseLendingCurrent	455354000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	384010000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	391626000	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	329361000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	311508000	usd
CY2023Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	140922000	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	81528000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	611098000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	557009000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	9046400000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	8528681000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1458857000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1386261000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	833269000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	836041000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	4933818000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4868382000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1983009000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1915725000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2152939000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2192706000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	980741000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1033011000	usd
CY2023Q1	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	950985000	usd
CY2022Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	973635000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	1295088000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1317705000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	138690000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	137480000	usd
CY2023Q1	us-gaap	Real Estate Held For Development And Sale RealEstateHeldForDevelopmentAndSale	180290000	usd
CY2022Q4	us-gaap	Real Estate Held For Development And Sale RealEstateHeldForDevelopmentAndSale	172253000	usd
CY2023Q1	us-gaap	Income Taxes Receivable Noncurrent IncomeTaxesReceivableNoncurrent	59471000	usd
CY2022Q4	us-gaap	Income Taxes Receivable Noncurrent IncomeTaxesReceivableNoncurrent	51910000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	274843000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	265554000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1134548000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1109666000	usd
CY2023Q1	us-gaap	Assets Assets	21030097000	usd
CY2022Q4	us-gaap	Assets Assets	20513389000	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	3008485000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	3078781000	usd
CY2023Q1	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	1410582000	usd
CY2022Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	1459001000	usd
CY2023Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	932619000	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1691118000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	232369000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	229591000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	262189000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	276334000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	192754000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	184453000	usd
CY2023Q1	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	782637000	usd
CY2022Q4	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	447840000	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1209000000	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	178000000	usd
CY2023Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	17153000	usd
CY2022Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	42914000	usd
CY2023Q1	us-gaap	Debt Current DebtCurrent	2008790000	usd
CY2022Q4	us-gaap	Debt Current DebtCurrent	668754000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	433433000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	427792000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	236241000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	226170000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8717462000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8241994000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1086268000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1085712000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1052823000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1080385000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	54761000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	54761000	usd
CY2023Q1	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	154943000	usd
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	148806000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	276681000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	282073000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1044749000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1013926000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	12387687000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	11907657000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	525000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	525000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	310786159	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	310786159	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	311014160	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	311014160	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	3108000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	3110000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	0	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	0	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	8809824000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	8832943000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-953098000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-982780000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	7859834000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7853273000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	782576000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	752459000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8642410000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8605732000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21030097000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20513389000	usd
CY2023Q1	us-gaap	Revenues Revenues	7411114000	usd
CY2022Q1	us-gaap	Revenues Revenues	7332933000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	6006413000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	5752194000	usd
CY2023Q1	cbre	Operating Administrative And Other Expenses OperatingAdministrativeAndOtherExpenses	1208904000	usd
CY2022Q1	cbre	Operating Administrative And Other Expenses OperatingAdministrativeAndOtherExpenses	1065996000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	161491000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	149032000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	10351000	usd
CY2023Q1	cbre	Cost And Expenses Excluding Gain On Disposition Of Real Estate Assets CostAndExpensesExcludingGainOnDispositionOfRealEstateAssets	7376808000	usd
CY2022Q1	cbre	Cost And Expenses Excluding Gain On Disposition Of Real Estate Assets CostAndExpensesExcludingGainOnDispositionOfRealEstateAssets	6977573000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	3059000	usd
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	21592000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	37365000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	376952000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	141682000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	42871000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2475000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-14464000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-28414000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-12826000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	153108000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	392533000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28036000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3738000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	125072000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	396271000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	8180000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3974000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	116892000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	392297000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.18
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	310464609	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	331925104	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.37
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.16
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	315358147	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	337140325	shares
CY2023Q1	us-gaap	Profit Loss ProfitLoss	125072000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	396271000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	37734000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-81285000	usd
CY2023Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-110000	usd
CY2022Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-108000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-70000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1731000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	5558000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	100000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	43332000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-82808000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	168404000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	313463000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	21830000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-18053000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	146574000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	331516000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	125072000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	42871000	usd
CY2023Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	177710000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	396271000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	161491000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	149032000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1161000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1663000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	23481000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	28422000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	10351000	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-319000	usd
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-16690000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3969000	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3303000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	18113000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	36863000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	141682000	usd
CY2022Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	146743000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	2166609000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	3336084000	usd
CY2023Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	2494589000	usd
CY2022Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	3221312000	usd
CY2023Q1	cbre	Increase Decrease In Warehouse Lines Of Credit IncreaseDecreaseInWarehouseLinesOfCredit	334797000	usd
CY2022Q1	cbre	Increase Decrease In Warehouse Lines Of Credit IncreaseDecreaseInWarehouseLinesOfCredit	-105326000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	-528000	usd
CY2022Q1	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	-2114000	usd
CY2023Q1	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	2137000	usd
CY2022Q1	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	8902000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	2120000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	20750000	usd
CY2023Q1	cbre	Increase Decrease In Real Estate Under Development IncreaseDecreaseInRealEstateUnderDevelopment	5943000	usd
CY2022Q1	cbre	Increase Decrease In Real Estate Under Development IncreaseDecreaseInRealEstateUnderDevelopment	41358000	usd
CY2023Q1	cbre	Increase Decrease In Receivables Prepaid Expenses And Other Assets Including Contract Assets IncreaseDecreaseInReceivablesPrepaidExpensesAndOtherAssetsIncludingContractAssets	73437000	usd
CY2022Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	44387000	usd
CY2023Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	14794000	usd
CY2022Q1	cbre	Increase Decrease In Receivables Prepaid Expenses And Other Assets Including Contract Assets IncreaseDecreaseInReceivablesPrepaidExpensesAndOtherAssetsIncludingContractAssets	156061000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-73960000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-108355000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-843509000	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-725216000	usd
CY2023Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	56713000	usd
CY2022Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-17722000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	21195000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	93270000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-744757000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-393507000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	60284000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	42056000	usd
CY2023Q1	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	44653000	usd
CY2022Q1	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	16792000	usd
CY2023Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	28998000	usd
CY2022Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	12101000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-4074000	usd
CY2022Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	4487000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-115067000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-95621000	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1660000000	usd
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	210000000	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	629000000	usd
CY2022Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2023Q1	cbre	Proceeds From Notes Payable On Real Estate ProceedsFromNotesPayableOnRealEstate	48000	usd
CY2022Q1	cbre	Proceeds From Notes Payable On Real Estate ProceedsFromNotesPayableOnRealEstate	19368000	usd
CY2023Q1	cbre	Repayment Of Notes Payable On Real Estate RepaymentOfNotesPayableOnRealEstate	0	usd
CY2022Q1	cbre	Repayment Of Notes Payable On Real Estate RepaymentOfNotesPayableOnRealEstate	13954000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	129808000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	367863000	usd
CY2023Q1	cbre	Payments To Acquire Business Financing Activities PaymentsToAcquireBusinessFinancingActivities	60034000	usd
CY2022Q1	cbre	Payments To Acquire Business Financing Activities PaymentsToAcquireBusinessFinancingActivities	13556000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	46161000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	31395000	usd
CY2023Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	567000	usd
CY2022Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	210000	usd
CY2023Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	101000	usd
CY2022Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	213000	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-34474000	usd
CY2022Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-11606000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	761037000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-209009000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13727000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-49015000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-85060000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-747152000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1404849000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2539781000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1319789000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1792629000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	39379000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	12826000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	82059000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	88649000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8605732000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	125072000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18113000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	46161000	usd
CY2023Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	114249000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	37734000	usd
CY2023Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-110000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-70000	usd
CY2023Q1	cbre	Noncontrolling Interest Increase From Contributions From Noncontrolling Interest Holders NoncontrollingInterestIncreaseFromContributionsFromNoncontrollingInterestHolders	567000	usd
CY2023Q1	us-gaap	Basis Of Accounting BasisOfAccounting	Basis of Presentation<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Readers of this Quarterly Report on Form 10-Q (Quarterly Report) should refer to the audited financial statements and notes to consolidated financial statements of CBRE Group, Inc., a Delaware corporation (which may be referred to in these financial statements as “the company,” “we,” “us” and “our”), for the year ended December 31, 2022, which are included in our </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1138118/000113811823000009/cbre-20221231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022 Annual Report on Form 10-K (2022 Annual Report)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed with the United States Securities and Exchange Commission (SEC) and also available on our website (www.cbre.com), since we have omitted from this Quarterly Report certain footnote disclosures which would substantially duplicate those contained in such audited financial statements. You should also refer to Note 2, Significant Accounting Policies, in the notes to consolidated financial statements in our </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1138118/000113811823000009/cbre-20221231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion of our significant accounting policies and estimates.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Considerations Related to Tightening Monetary Policy </span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The macroeconomic environment remains challenging as central banks continue to rapidly raise interest rates. The rising rate environment, coupled with certain bank failures in the first quarter of 2023, has limited credit availability to all asset classes, including commercial real estate. Less available and more expensive debt capital has had pronounced effects on our capital markets (mortgage origination and property sales) businesses, making property acquisitions and dispositions harder to finance. Similar factors also impact the timing of and proceeds generated from asset sales within our investment management and development businesses and our ability to obtain debt capital to begin new development projects.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Statement Preparation</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with the rules applicable to quarterly reports on Form 10-Q and include all information and footnotes required for interim financial statement presentation, but do not include all disclosures required under accounting principles generally accepted in the United States (U.S.), or General Accepted Accounting Principles (GAAP), for annual financial statements. In our opinion, all adjustments (consisting of normal recurring adjustments, except as otherwise noted) considered necessary for a fair presentation have been included. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions about future events, such as weakening global macroeconomic conditions and stress in the banking system, including less available and more expensive debt capital. These estimates and the underlying assumptions affect the reported amounts of assets, liabilities, revenues and expenses. Such estimates include the value of goodwill, intangibles and other long-lived assets, real estate assets, accounts receivable, contract assets, operating lease assets, investments in unconsolidated subsidiaries and assumptions used in the calculation of income taxes, retirement and other post-employment benefits, among others. These estimates and assumptions are based on our best judgment. We evaluate our estimates and assumptions on an ongoing basis using historical experience and other factors, including consideration of the current economic environment, and adjust such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in these estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods.</span></div>
CY2023Q1	cbre	Loan Receivable Mortgage Warehouse Lending Current LoanReceivableMortgageWarehouseLendingCurrent	792294000	usd
CY2023Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	101000	usd
CY2023Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	-15663000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8642410000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9359117000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	396271000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	36863000	usd
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	31395000	usd
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	390863000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-81285000	usd
CY2022Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-108000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1731000	usd
CY2022Q1	cbre	Noncontrolling Interest Increase From Contributions From Noncontrolling Interest Holders NoncontrollingInterestIncreaseFromContributionsFromNoncontrollingInterestHolders	210000	usd
CY2022Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	213000	usd
CY2022Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	4257000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9282825000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions about future events, such as weakening global macroeconomic conditions and stress in the banking system, including less available and more expensive debt capital. These estimates and the underlying assumptions affect the reported amounts of assets, liabilities, revenues and expenses. Such estimates include the value of goodwill, intangibles and other long-lived assets, real estate assets, accounts receivable, contract assets, operating lease assets, investments in unconsolidated subsidiaries and assumptions used in the calculation of income taxes, retirement and other post-employment benefits, among others. These estimates and assumptions are based on our best judgment. We evaluate our estimates and assumptions on an ongoing basis using historical experience and other factors, including consideration of the current economic environment, and adjust such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in these estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods.
CY2022Q4	cbre	Loan Receivable Mortgage Warehouse Lending Current LoanReceivableMortgageWarehouseLendingCurrent	455354000	usd
CY2023Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	2494589000	usd
CY2023Q1	us-gaap	Gain Loss On Sales Of Mortgage Backed Securities Mbs GainLossOnSalesOfMortgageBackedSecuritiesMBS	6807000	usd
CY2023Q1	cbre	Sale Of Mortgage Loans Held For Sale SaleOfMortgageLoansHeldForSale	2159802000	usd
CY2023Q1	us-gaap	Proceeds From Collection Of Mortgage Loans Held For Sale ProceedsFromCollectionOfMortgageLoansHeldForSale	6807000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	2166609000	usd
CY2023Q1	cbre	Net Increase Decrease In Mortgage Servicing Rights Included In Warehouse Receivables NetIncreaseDecreaseInMortgageServicingRightsIncludedInWarehouseReceivables	2153000	usd
CY2023Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	100700000	usd
CY2023Q1	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Planned Sale Investments Not Identified Value FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePlannedSaleInvestmentsNotIdentifiedValue	359900000	usd
CY2022Q4	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Planned Sale Investments Not Identified Value FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePlannedSaleInvestmentsNotIdentifiedValue	353000000	usd
CY2022Q4	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	14452000	usd
CY2023Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Out Of Level3 FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3	0	usd
CY2023Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings	-3400000	usd
CY2023Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Purchases FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchases	2593000	usd
CY2023Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	20445000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	10400000	usd
CY2022Q4	us-gaap	Assets Designated To Closed Block Trading Securities Debt AssetsDesignatedToClosedBlockTradingSecuritiesDebt	10000000	usd
CY2023Q1	cbre	Notes Payable On Real Estate NotesPayableOnRealEstate	55900000	usd
CY2022Q4	cbre	Notes Payable On Real Estate NotesPayableOnRealEstate	52700000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	1295088000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1317705000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1525585000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1519642000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	433433000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	427792000	usd
CY2023Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	5884000	usd
CY2022Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	6138000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1086268000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1085712000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	980741000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1033011000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	90509000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	91028000	usd
CY2023Q1	cbre	Operating And Finance Lease Right Of Use Asset OperatingAndFinanceLeaseRightOfUseAsset	1071250000	usd
CY2022Q4	cbre	Operating And Finance Lease Right Of Use Asset OperatingAndFinanceLeaseRightOfUseAsset	1124039000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	232369000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	229591000	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	33984000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	33039000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1052823000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1080385000	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	57124000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	58094000	usd
CY2023Q1	cbre	Operating And Financing Lease Liability OperatingAndFinancingLeaseLiability	1376300000	usd
CY2022Q4	cbre	Operating And Financing Lease Liability OperatingAndFinancingLeaseLiability	1401109000	usd
CY2023Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	215200000	usd
CY2023Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	215200000	usd
CY2023Q1	cbre	Guarantor Obligations Maximum Exposure Undiscounted GuarantorObligationsMaximumExposureUndiscounted	388900000	usd
CY2023Q1	cbre	Guarantor Obligations Maximum Exposure Undiscounted GuarantorObligationsMaximumExposureUndiscounted	388900000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	39998000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	14784000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	8004000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	9415000	usd
CY2023Q1	cbre	Other Noncash Increases Decreases In Operating Lease Right Of Use Assets OtherNoncashIncreasesDecreasesInOperatingLeaseRightOfUseAssets	-52701000	usd
CY2022Q1	cbre	Other Noncash Increases Decreases In Operating Lease Right Of Use Assets OtherNoncashIncreasesDecreasesInOperatingLeaseRightOfUseAssets	25346000	usd
CY2023Q1	cbre	Other Noncash Increases Decreases In Finance Lease Right Of Use Assets OtherNoncashIncreasesDecreasesInFinanceLeaseRightOfUseAssets	151000	usd
CY2022Q1	cbre	Other Noncash Increases Decreases In Finance Lease Right Of Use Assets OtherNoncashIncreasesDecreasesInFinanceLeaseRightOfUseAssets	-989000	usd
CY2023Q1	cbre	Funded Loan Principal Amount Outstanding FundedLoanPrincipalAmountOutstanding	39500000000	usd
CY2023Q1	cbre	Loan Loss Sharing Reserve LoanLossSharingReserve	66200000	usd
CY2022Q4	cbre	Loan Loss Sharing Reserve LoanLossSharingReserve	65100000	usd
CY2023Q1	cbre	Assets Available For Recourse AssetsAvailableForRecourse	894600000	usd
CY2023Q1	cbre	Investment Funds Maximum Equity In Real Estate Investment Percent InvestmentFundsMaximumEquityInRealEstateInvestmentPercent	0.020
CY2023Q1	cbre	Commitments To Investment In Future Real Estate Investment CommitmentsToInvestmentInFutureRealEstateInvestment	93100000	usd
CY2023Q1	cbre	Real Estate Investments Maximum Equity In Real Estate Investment Percent RealEstateInvestmentsMaximumEquityInRealEstateInvestmentPercent	0.50
CY2023Q1	cbre	Other Commitment Capital Investment In Consolidated Projects OtherCommitmentCapitalInvestmentInConsolidatedProjects	135300000	usd
CY2023Q1	cbre	Other Commitment Capital Investment In Unconsolidated Entity OtherCommitmentCapitalInvestmentInUnconsolidatedEntity	96700000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28000000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3700000	usd
CY2023Q1	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	31800000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.183
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.010
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	399700000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	391400000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	8300000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	116892000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	392297000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	310464609	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	331925104	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.18
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	116892000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	392297000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	310464609	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	331925104	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	4893538	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	5215221	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	315358147	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	337140325	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.37
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.16
CY2023Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	2000000000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7302479000	usd
CY2023Q1	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	108635000	usd
CY2023Q1	us-gaap	Revenues Revenues	7411114000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7168411000	usd
CY2022Q1	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	164522000	usd
CY2022Q1	us-gaap	Revenues Revenues	7332933000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	522700000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	384000000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	529100000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	391600000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	268800000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	262200000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	284300000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	276300000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-183200000	usd
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023Q1	us-gaap	Revenues Revenues	7411114000	usd
CY2022Q1	us-gaap	Revenues Revenues	7332933000	usd
CY2023Q1	cbre	Adjusted Earnings Before Interest Taxes Depreciation And Amortization AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization	630886000	usd
CY2022Q1	cbre	Adjusted Earnings Before Interest Taxes Depreciation And Amortization AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization	835442000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	116892000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	392297000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	8180000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3974000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	125072000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	396271000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	161491000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	149032000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	10351000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-28414000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-12826000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28036000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3738000	usd
CY2023Q1	cbre	Carried Interest Incentive Compensation Expense Reversal CarriedInterestIncentiveCompensationExpenseReversal	6978000	usd
CY2022Q1	cbre	Carried Interest Incentive Compensation Expense Reversal CarriedInterestIncentiveCompensationExpenseReversal	22856000	usd
CY2023Q1	cbre	Impact Of Fair Value Adjustments To Assets Acquired In Business ImpactOfFairValueAdjustmentsToAssetsAcquiredInBusiness	0	usd
CY2022Q1	cbre	Impact Of Fair Value Adjustments To Assets Acquired In Business ImpactOfFairValueAdjustmentsToAssetsAcquiredInBusiness	-1696000	usd
CY2023Q1	us-gaap	Restructuring Costs RestructuringCosts	0	usd
CY2022Q1	us-gaap	Restructuring Costs RestructuringCosts	1676000	usd
CY2023Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	18134000	usd
CY2022Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	8121000	usd
CY2023Q1	cbre	Costs Associated With Efficiency And Cost Reduction Initiatives CostsAssociatedWithEfficiencyAndCostReductionInitiatives	138247000	usd
CY2022Q1	cbre	Costs Associated With Efficiency And Cost Reduction Initiatives CostsAssociatedWithEfficiencyAndCostReductionInitiatives	0	usd
CY2023Q1	cbre	Adjusted Earnings Before Interest Taxes Depreciation And Amortization AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization	630886000	usd
CY2022Q1	cbre	Adjusted Earnings Before Interest Taxes Depreciation And Amortization AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization	835442000	usd
CY2023Q1	us-gaap	Revenues Revenues	7411114000	usd
CY2022Q1	us-gaap	Revenues Revenues	7332933000	usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	138200000	usd

Files In Submission

Name	View Source	Status
cbre-20230331_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cbre-20230331_cal.xml	Edgar Link	unprocessable
0001138118-23-000015-index-headers.html	Edgar Link	pending
0001138118-23-000015-index.html	Edgar Link	pending
0001138118-23-000015.txt	Edgar Link	pending
0001138118-23-000015-xbrl.zip	Edgar Link	pending
cbre-20230331.htm	Edgar Link	pending
cbre-20230331.xsd	Edgar Link	pending
cbre-20230331x10qxex221.htm	Edgar Link	pending
cbre-20230331x10qxex311.htm	Edgar Link	pending
cbre-20230331x10qxex312.htm	Edgar Link	pending
cbre-20230331x10qxex32.htm	Edgar Link	pending
cbre-20230331_g1.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
cbre-20230331_lab.xml	Edgar Link	unprocessable
cbre-20230331_pre.xml	Edgar Link	unprocessable
cbre-20230331_htm.xml	Edgar Link	completed
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CBRE
CBRE GROUP, INC. Stock $cbre

2023 Q2 Form 10-Q Financial Statement

#000113811823000015 Filed on April 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBRE CBRE GROUP, INC. Stock $cbre

2023 Q2 Form 10-Q Financial Statement

#000113811823000015 Filed on April 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBRE
CBRE GROUP, INC. Stock $cbre